DK0929270T3 - Oral pharmaceutical products with peptides - Google Patents

Oral pharmaceutical products with peptides

Info

Publication number
DK0929270T3
DK0929270T3 DK97915071T DK97915071T DK0929270T3 DK 0929270 T3 DK0929270 T3 DK 0929270T3 DK 97915071 T DK97915071 T DK 97915071T DK 97915071 T DK97915071 T DK 97915071T DK 0929270 T3 DK0929270 T3 DK 0929270T3
Authority
DK
Denmark
Prior art keywords
peptides
pharmaceutical products
oral pharmaceutical
oral
products
Prior art date
Application number
DK97915071T
Other languages
Danish (da)
Inventor
William Stern
James P Gilligan
Original Assignee
Unigene Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unigene Lab Inc filed Critical Unigene Lab Inc
Priority claimed from PCT/US1997/004024 external-priority patent/WO1997033531A1/en
Application granted granted Critical
Publication of DK0929270T3 publication Critical patent/DK0929270T3/en

Links

DK97915071T 1997-03-14 1997-03-14 Oral pharmaceutical products with peptides DK0929270T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/004024 WO1997033531A1 (en) 1996-03-15 1997-03-14 Oral peptide pharmaceutical products

Publications (1)

Publication Number Publication Date
DK0929270T3 true DK0929270T3 (en) 2005-03-21

Family

ID=34311755

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97915071T DK0929270T3 (en) 1997-03-14 1997-03-14 Oral pharmaceutical products with peptides

Country Status (1)

Country Link
DK (1) DK0929270T3 (en)

Similar Documents

Publication Publication Date Title
ID24654A (en) OMEPRAZOLA PHARMACEUTICAL FORMULATION
BR9611367A (en) Stable lyophilized pharmaceutical formulation
DE69525148D1 (en) PHARMACEUTICAL FORMULATION
NO20001776L (en) drugs
EE200000395A (en) Oral pharmaceutical pulsatile dosage form
NO20003218L (en) Oral pharmaceutical dosage form with prolonged release effect
NO971422D0 (en) drugs
NO954486D0 (en) Pharmaceutical formulation basis
BR9610153A (en) Pharmaceutical formulations
BR9611626A (en) Pharmaceutical formulations
DE59712959D1 (en) ORAL PHARMACEUTICAL PREPARATION CONTAINING IBANDRONAT
DE69737936D1 (en) DRUG
NO981008D0 (en) Pharmaceutical formulation
NO980546D0 (en) Pharmaceutical agents
NO20020531D0 (en) Beta-carbolin drug products
DK1017392T3 (en) Medicines
NO982874D0 (en) Pharmaceutical preparations with vitamin D analogues
DE69820861D1 (en) PARTICULATE MEDICINAL PRODUCTS
ID16781A (en) PHARMACEUTICAL FORMULATIONS
ID29294A (en) PHARMACEUTICAL COMPOSITION
ITMI941169A0 (en) PHARMACEUTICAL FORMULATIONS
ID30032A (en) PHARMACEUTICAL FORMULATION
NO20003141D0 (en) Pharmaceutical mixtures
EE9800275A (en) Prolonged-release pharmaceutical preparations containing misolastin
FI973230A (en) New pharmaceutical formulation